Page last updated: 2024-08-23

paclitaxel and Hematologic Malignancies

paclitaxel has been researched along with Hematologic Malignancies in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Kim, D; Kim, M; Kim, R; Kim, S; Kim, Y; Koh, Y; Ku, J; Kwon, NH; Lee, K; Lee, N; Song, S; Yoon, SS1
Hu, WH; Jin, T; Li, PJ; Luo, DH; Mo, HY1
Choi, M; Gadgeel, SM; Heilbrun, LK; Jiang, PQ; Smith, DW1
De Arriba, F; Fernández, A; Heras, I; Lozano, ML; Rivera, J; Vicente, V1
Adamo, L; Conticello, C; De Maria, R; Giannone, I; Gulisano, M; Musumeci, T; Pignatello, R; Puglisi, G; Vicari, L1
Bane, FT; Bannon, JH; Campaini, G; Campiani, G; Mc Gee, MM; Pennington, SR; Williams, DC; Zisterer, DM1
Burzynski, J; Callander, N; Freytes, C; Greene, R; McKibbin, T; Ochoa-Bayona, J; Tsai, TW1

Other Studies

7 other study(ies) available for paclitaxel and Hematologic Malignancies

ArticleYear
Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer.
    Communications biology, 2020, 10-30, Volume: 3, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alternative Splicing; Cell Line, Tumor; Drug Resistance, Neoplasm; Exons; Female; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Image Processing, Computer-Assisted; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Targeted Therapy; Nuclear Proteins; Paclitaxel; Prognosis; Single-Cell Analysis; Young Adult

2020
The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
    Oral oncology, 2018, Volume: 85

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Hematologic Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Progression-Free Survival; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome

2018
Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center.
    Critical reviews in oncology/hematology, 2008, Volume: 67, Issue:3

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carboplatin; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Neoplasms; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thoracic Neoplasms; Treatment Outcome; Urogenital Neoplasms

2008
Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies.
    Haematologica, 2008, Volume: 93, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cell Movement; Female; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Paclitaxel; Salvage Therapy

2008
Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.
    BMC cancer, 2008, Jul-25, Volume: 8

    Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Colloids; Coumarins; Drug Carriers; Hematologic Neoplasms; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Neoplasms; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer

2008
The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1,
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Division; Cell Membrane; Cell Nucleus; Cyclophilin A; Cytoplasm; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; G2 Phase; Hematologic Neoplasms; Humans; Hydrolysis; Microtubules; Monocytes; NIMA-Interacting Peptidylprolyl Isomerase; Oxazepines; Paclitaxel; Peptide Mapping; Peptidylprolyl Isomerase; Pyrroles; Silver Staining; Trypsin

2009
Paclitaxel and filgrastim for hematopoietic progenitor cell mobilization in patients with hematologic malignancies after failure of a prior mobilization regimen.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:12

    Topics: Aged; Antigens, CD34; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Middle Aged; Paclitaxel; Recombinant Proteins; Transplantation, Autologous; Treatment Failure

2007